OXB13 is an androgen receptor co-regulator specifically expressed in cells of prostatic lineage. The authors sought to associate circulating tumor cell HOXB13 expression with outcomes in men with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
[Clinical Cancer Research]
